Hiroko Hirooka
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Aldose Reductase and Taurine
Papers in
-
- Aldose Reductase and Taurine 6
-
- Receptor Mechanisms and Signaling 2
- Metabolism, Diabetes, and Cancer 1
- Co-authors
- Irina G. Obrosova (2 shared papers)Martin J. Stevens (1 shared paper)Zsuzsanna K. Zsengellér (1 shared paper)Mark A. Yorek (1 shared paper)Csaba Szabó (1 shared paper)Pál Pacher (1 shared paper)Takayuki Negishi (1 shared paper)Yasuhiro Yoshikawa (1 shared paper)
- Journals
- Biological and Pharmaceutical Bulletin (2 papers)Biochemical and Biophysical Research Communications (2 papers)Diabetes (1 paper)Toxicology (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroko Hirooka
11 papers receiving 358 citations
Peers
Comparison fields: 5 of 74
- Clinical Biochemistry 77
- Cell Biology 97
- Health, Toxicology and Mutagenesis 59
- Ophthalmology 39
- Physiology 107
Countries citing papers authored by Hiroko Hirooka
This map shows the geographic impact of Hiroko Hirooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Hirooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Hirooka more than expected).
Fields of papers citing papers by Hiroko Hirooka
This network shows the impact of papers produced by Hiroko Hirooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Hirooka. The network helps show where Hiroko Hirooka may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Hirooka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 141 | |
| 2 | 2006 | 68 | |
| 3 | 2006 | 52 | |
| 4 | 2002 | 47 | |
| 5 | 2012 | 29 | |
| 6 | 2013 | 8 | |
| 7 | 2003 | 8 | |
| 8 | 2008 | 7 | |
| 9 | 1998 | 6 | |
| 10 | 1998 | 2 | |
| 11 | 2005 | 1 |
About Hiroko Hirooka
Hiroko Hirooka is a scholar working on Cell Biology, Molecular Biology, Clinical Biochemistry, Physiology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 369 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (6 papers), Advanced Glycation End Products research (4 papers), Biochemical effects in animals (2 papers), Alcohol Consumption and Health Effects (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Receptor Mechanisms and Signaling (2 papers), Metabolism, Diabetes, and Cancer (1 paper) and Effects and risks of endocrine disrupting chemicals (1 paper). The work is most often cited by research in Clinical Biochemistry (77 citations), Cell Biology (97 citations), Health, Toxicology and Mutagenesis (59 citations), Ophthalmology (39 citations) and Physiology (107 citations). Hiroko Hirooka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Irina G. Obrosova, Martin J. Stevens, Zsuzsanna K. Zsengellér, Mark A. Yorek, Csaba Szabó, Pál Pacher, Takayuki Negishi, Yasuhiro Yoshikawa, Atsushi Miyachi and Ikuo Hayasaka. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Biochemical and Biophysical Research Communications, Diabetes, Toxicology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.